February 1, 2021
CT Testimony on Data Regarding IZ Rates
2017 testimony from the Connecticut Department of Public Health on Senate Bill 840 which would allow the Department to provide unidentifiable, aggregate data…
February 1, 2021
OR Testimony on Senate Bill 869
2017 Testimony from OR IP on Senate Bill 869, which requires providers to distribute the VIS, explain vaccine risks and benefits, and make…
February 1, 2021
MN: Analysis on Informed Consent Bill
Analysis of Minnesota bill requiring 1) VIS distribution, 2) written consent before vaccination, 3) VAERS reporting, 4) providers to send the commissioner a…
January 29, 2021
ASTHO and AIM Request for Additional State and Territorial Vaccination Needs
Association of State and Territorial Health Officials and AIM’s letter in support of emergency supplemental funding dedicated to a national vaccination program.
January 26, 2021
ND Legislator Education on HB 1469
Document provided by ND IP, Molly Howell, to legislators in response to House Bill 1469. HB 1469 requires the State Department of Health…
January 26, 2021
ND Testimony on House Bill 1468
North Dakota IP, Molly Howell, provides testimony on HB 1468, a bill related to informed consent which requires patients receive the vaccine package…
January 26, 2021
ND Testimony on House Bill 1320
Testimony from the ND IP on the importance of childcare, school, and university immunization requirements.
January 25, 2021
ND Testimony on HB 1377
Testimony from North Dakota IP, Molly Howell, on House Bill 1377 which allows for immunization exemptions for any reason if a vaccine is…
January 14, 2021
Preparing for the 2021 Legislative Session
This webinar provided a legislative update, tips for managing the 2021 legislative session, and a background on mandates.
December 20, 2020
Public Comments to ACIP Emergency Meeting on Moderna COVID-19 Vaccine
The guidance provided by ACIP is extremely valuable and will help jurisdictions make decisions. The balanced considerations for preventing death and supporting societal function help provide context to the phased rollout.